Q-omics provides the consensus-scored MTND4P33 profile across patient tissues and cancer cell-line models. MTND4P33 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, MTND4P33 RNA expression shows 5,438 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where MTND4P33 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTND4P33 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTND4P33 survival associations across molecular data types. MTND4P33 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTND4P33 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	LIHC (99)	view →

This table ranks reproducible MTND4P33 RNA expression–survival associations across cancer types. High MTND4P33 expression shows unfavorable associations in LIHC, KIRP, BRCA, KIRC, LUAD and SARC. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for MTND4P33 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.098	0.557	<.001	99	view →
KIRP	OS	Tertile	All	0.206	0.712	<.001	96	view →
BRCA	OS	Tertile	II,III,IV	0.719	0.916	.002	84	view →
KIRC	DFS	Tertile	All	0.450	0.806	.001	36	view →
LUAD	OS	Tertile	II,III,IV	0.373	0.752	.028	18	view →
SARC	DFS	Tertile	All	0.169	0.635	.005	18	view →

Pink = unfavorable, green = favorable. all 8 lineages →

MTND4P33-LIHC (DFS)

Kaplan–Meier survival curve for MTND4P33 RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTND4P33 in patient tissues and cancer cell lines. In patient samples, MTND4P33 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,438	STAD (5275)	view →
RNA	2,174	COAD (651)	view →